2019 American Transplant Congress
Impact Of Selective Cd28 Blockade On Protective Immunity To A Murine Epstein-Barr Virus Homolog
Surgery, Emory University, ATLANTA, GA
*Purpose: CTLA-4Ig blocks CD80/CD86, the ligands for both CD28 and CTLA-4. Thus, in addition to the intended effect of blocking CD28-mediated costimulation, CTLA4-Ig also has…2019 American Transplant Congress
Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients
Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Tocilizumab blocks IL-6 signaling, inhibiting maturation of B cells to plasma cells and antibody production. We have used tocilizumab since 2012 to treat kidney…2019 American Transplant Congress
Development of a Pharmacy Collaborative Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic
*Purpose: This study describes the development of a Collaborative Pharmacy Practice Agreement (CPPA) between transplant pharmacists and physicians and assesses change in prescription volume and…2019 American Transplant Congress
The Effect Of Tacrolimus Trough Variability On Kidney Transplant Outcomes
*Purpose: High variability in tacrolimus as assessed by tacrolimus coefficient of variability (TCV) in trough levels of kidney transplant recipients (KTRs) has been associated with…2019 American Transplant Congress
Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus
Columbia University MC, New York, NY
*Purpose: Lupus nephritis (LN) results in the need for renal replacement therapy (RRT) in 10-30% of LN pts and 30% receive a kidney transplant (KT).…2019 American Transplant Congress
Patient Reported Side Effects Associated with Reduced Quality of Life after Living Donor Kidney Transplant
Northwestern University, Chicago, IL
*Purpose: As living donor kidney transplant (LDKT) graft and patient survival approaches 100%, the focus of care turns to patient reported outcome measures such as…2019 American Transplant Congress
Comparison of Tacrolimus or Cyclosporine Combined with Methotrexate for Graft versus Host Disease Prophylaxis after Allogeneic Hematopoietic Cell Transplantation: A Meta-Analysis
Transplant Center, Sun Yat-sen University, Guangzhou, China
*Purpose: After patients received hematopoietic stem cell transplantation (HSCT) ,both cyclosporine (CsA) and tacrolimus (TAC) in combination with methotrexate (MTX) have been recommended as standard…2019 American Transplant Congress
Efficacy and Safety of Everolimus in Pediatric Renal Transplantation
*Purpose: There are scarce evidence on the efficacy and safety of everolimus (EVR)-based regimens in pediatric kidney transplantation (KT).*Methods: This single center retrospective cohort analyzed…2019 American Transplant Congress
Induction Immunosuppression Practices in Liver Transplantation are Variable and Predict Post-Transplant Survival
*Purpose: Unlike in other solid organ transplants, the benefits of induction immunosuppression prior to liver transplantation (LT) remain uncertain. The objective of this study was…2019 American Transplant Congress
Determining the Role of Insurance Coverage at the Time of Renal Transplantation as a Predictor of Medication Misadventure
Pharmacy, University of Colorado Skaggs School of Pharmacy, Aurora, CO
*Purpose: To determine if patients who receive financial assistance through the American Kidney Fund (AKF) for health care premiums at the time of transplant are…
- « Previous Page
- 1
- …
- 53
- 54
- 55
- 56
- 57
- …
- 138
- Next Page »